Cargando…
(99m)Tc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model
BACKGROUND: Since proteoglycans (PGs) appear as key partners in chondrosarcoma biology, PG-targeted imaging using the radiotracer (99m)Tc-N-(triethylammonium)-3-propyl-[15]ane-N5 ((99m)Tc-NTP 15-5) developed by our group was previously demonstrated to be a good single-photon emission computed tomogr...
Autores principales: | Miot-Noirault, Elisabeth, David, Emmanuelle, Vidal, Aurélien, Peyrode, Caroline, Besse, Sophie, Dauplat, Marie-Mélanie, Heymann, Marie-Françoise, Gouin, François, Chezal, Jean-Michel, Heymann, Dominique, Rédini, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665493/ https://www.ncbi.nlm.nih.gov/pubmed/23688107 http://dx.doi.org/10.1186/2191-219X-3-40 |
Ejemplares similares
-
A“Proteoglycan Targeting Strategy” for the Scintigraphic Imaging and Monitoring of the Swarm Rat Chondrosarcoma Orthotopic Model
por: Peyrode, Caroline, et al.
Publicado: (2011) -
Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept
por: Voissiere, Aurélien, et al.
Publicado: (2017) -
Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing
por: Voissiere, Aurélien, et al.
Publicado: (2017) -
Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration
por: Odri, Guillaume, et al.
Publicado: (2014) -
The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets
por: David, E., et al.
Publicado: (2011)